BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28632884)

  • 1. Components of the alternative complement pathway in patients with psoriasis.
    Sereflican B; Bugdayci G
    Acta Dermatovenerol Alp Pannonica Adriat; 2017 Jun; 26(2):37-40. PubMed ID: 28632884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice.
    Paglialunga S; Fisette A; Yan Y; Deshaies Y; Brouillette JF; Pekna M; Cianflone K
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E521-9. PubMed ID: 18160458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated fetal adipsin/acylation-stimulating protein (ASP) in obese pregnancy: novel placental secretion via Hofbauer cells.
    Sivakumar K; Bari MF; Adaikalakoteswari A; Guller S; Weickert MO; Randeva HS; Grammatopoulos DK; Bastie CC; Vatish M
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4113-22. PubMed ID: 23956345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipsin of the Alternative Complement Pathway Is a Potential Predictor for Preeclampsia in Early Pregnancy.
    Liu M; Luo X; Xu Q; Yu H; Gao L; Zhou R; Wang T
    Front Immunol; 2021; 12():702385. PubMed ID: 34671343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis.
    Cianflone K; Roncari DA; Maslowska M; Baldo A; Forden J; Sniderman AD
    Biochemistry; 1994 Aug; 33(32):9489-95. PubMed ID: 8068623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations.
    Maslowska M; Vu H; Phelis S; Sniderman AD; Rhode BM; Blank D; Cianflone K
    Eur J Clin Invest; 1999 Aug; 29(8):679-86. PubMed ID: 10457151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of complement alternative pathway in mice with Fab antibody to recombinant adipsin/factor D.
    Pascual M; Catana E; White T; Spiegelman BM; Schifferli JA
    Eur J Immunol; 1993 Jun; 23(6):1389-92. PubMed ID: 8500532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical evaluation of the putative role of C3adesArg (ASP) in lipid metabolism and hyperapobetalipoproteinemia.
    Kildsgaard J; Zsigmond E; Chan L; Wetsel RA
    Mol Immunol; 1999; 36(13-14):869-76. PubMed ID: 10698341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acylation-stimulating protein precursor proteins in adipose tissue in human obesity.
    Xia Z; Cianflone K
    Metabolism; 2003 Oct; 52(10):1360-6. PubMed ID: 14564690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation-induced production of ASP in human adipocytes.
    Cianflone K; Maslowska M
    Eur J Clin Invest; 1995 Nov; 25(11):817-25. PubMed ID: 8582446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of alternative pathway activation and C3a production by adipose cells.
    Choy LN; Spiegelman BM
    Obes Res; 1996 Nov; 4(6):521-32. PubMed ID: 8946437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis.
    Baldo A; Sniderman AD; St-Luce S; Avramoglu RK; Maslowska M; Hoang B; Monge JC; Bell A; Mulay S; Cianflone K
    J Clin Invest; 1993 Sep; 92(3):1543-7. PubMed ID: 8376604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of acylation-stimulating protein in interleukin-6-deficient (IL-6(-/-)) mice.
    Wernstedt I; Olsson B; Jernås M; Paglialunga S; Carlsson LM; Smith U; Cianflone K; Wallenius K; Wallenius V
    Endocrinology; 2006 Jun; 147(6):2690-5. PubMed ID: 16513824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement-mediated chronic inflammation is associated with diabetic microvascular complication.
    Fujita T; Hemmi S; Kajiwara M; Yabuki M; Fuke Y; Satomura A; Soma M
    Diabetes Metab Res Rev; 2013 Mar; 29(3):220-6. PubMed ID: 23280928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipsin and complement factor D activity: an immune-related defect in obesity.
    Rosen BS; Cook KS; Yaglom J; Groves DL; Volanakis JE; Damm D; White T; Spiegelman BM
    Science; 1989 Jun; 244(4911):1483-7. PubMed ID: 2734615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics and reproductive effects of complement factors in the spontaneous abortion model of CBA/J×DBA/2 mice.
    Takeshita A; Kusakabe KT; Hiyama M; Kuniyoshi N; Kondo T; Kano K; Kiso Y; Okada T
    Immunobiology; 2014 May; 219(5):385-91. PubMed ID: 24576554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acylation stimulating protein but not complement C3 associates with metabolic syndrome components in Chinese children and adolescents.
    Wamba PC; Mi J; Zhao XY; Zhang MX; Wen Y; Cheng H; Hou DQ; Cianflone K
    Eur J Endocrinol; 2008 Dec; 159(6):781-90. PubMed ID: 18805911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement Factor D (adipsin) Levels Are Elevated in Acquired Partial Lipodystrophy (Barraquer-Simons syndrome).
    Corvillo F; González-Sánchez L; López-Lera A; Arjona E; Ceccarini G; Santini F; Araújo-Vilar D; Brown RJ; Villarroya J; Villarroya F; Rodríguez de Córdoba S; Caballero T; Nozal P; López-Trascasa M
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modest release of adipsin/factor D by liposuction when using the superwet or tumescent technique.
    Samdal F; Mollnes TE; Amland PF; Truedsson L
    Plast Reconstr Surg; 1997 May; 99(6):1591-4; discussion 1595-6. PubMed ID: 9145127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes.
    Peake PW; Kriketos AD; Campbell LV; Charlesworth JA
    Int J Obes (Lond); 2005 Apr; 29(4):429-35. PubMed ID: 15111984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.